Logo image of BGS

B&G FOODS INC (BGS) Stock Fundamental Analysis

NYSE:BGS - New York Stock Exchange, Inc. - US05508R1068 - Common Stock - Currency: USD

6.755  -0.05 (-0.81%)

Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to BGS. BGS was compared to 89 industry peers in the Food Products industry. There are concerns on the financial health of BGS while its profitability can be described as average. BGS has a valuation in line with the averages, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

In the past year BGS was profitable.
In the past year BGS had a positive cash flow from operations.
In multiple years BGS reported negative net income over the last 5 years.
BGS had a positive operating cash flow in each of the past 5 years.
BGS Yearly Net Income VS EBIT VS OCF VS FCFBGS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M -200M

1.2 Ratios

BGS has a worse Return On Assets (-8.39%) than 74.16% of its industry peers.
BGS has a worse Return On Equity (-47.87%) than 76.40% of its industry peers.
BGS has a better Return On Invested Capital (6.12%) than 60.67% of its industry peers.
The Average Return On Invested Capital over the past 3 years for BGS is below the industry average of 9.00%.
The 3 year average ROIC (5.46%) for BGS is below the current ROIC(6.12%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA -8.39%
ROE -47.87%
ROIC 6.12%
ROA(3y)-3.53%
ROA(5y)-1.07%
ROE(3y)-19.04%
ROE(5y)-6.78%
ROIC(3y)5.46%
ROIC(5y)5.48%
BGS Yearly ROA, ROE, ROICBGS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40

1.3 Margins

BGS has a better Operating Margin (11.04%) than 77.53% of its industry peers.
In the last couple of years the Operating Margin of BGS has declined.
BGS's Gross Margin of 21.83% is in line compared to the rest of the industry. BGS outperforms 50.56% of its industry peers.
In the last couple of years the Gross Margin of BGS has remained more or less at the same level.
Industry RankSector Rank
OM 11.04%
PM (TTM) N/A
GM 21.83%
OM growth 3Y1.19%
OM growth 5Y-2.1%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.91%
GM growth 5Y-1.1%
BGS Yearly Profit, Operating, Gross MarginsBGS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20 30

3

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), BGS is destroying value.
The number of shares outstanding for BGS has been increased compared to 1 year ago.
BGS has more shares outstanding than it did 5 years ago.
The debt/assets ratio for BGS is higher compared to a year ago.
BGS Yearly Shares OutstandingBGS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
BGS Yearly Total Debt VS Total AssetsBGS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.2 Solvency

BGS has an Altman-Z score of 1.48. This is a bad value and indicates that BGS is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 1.48, BGS is in line with its industry, outperforming 40.45% of the companies in the same industry.
BGS has a debt to FCF ratio of 19.58. This is a negative value and a sign of low solvency as BGS would need 19.58 years to pay back of all of its debts.
BGS has a Debt to FCF ratio (19.58) which is comparable to the rest of the industry.
A Debt/Equity ratio of 3.84 is on the high side and indicates that BGS has dependencies on debt financing.
BGS has a Debt to Equity ratio of 3.84. This is amonst the worse of the industry: BGS underperforms 88.76% of its industry peers.
Industry RankSector Rank
Debt/Equity 3.84
Debt/FCF 19.58
Altman-Z 1.48
ROIC/WACC0.84
WACC7.32%
BGS Yearly LT Debt VS Equity VS FCFBGS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B 2B

2.3 Liquidity

BGS has a Current Ratio of 3.30. This indicates that BGS is financially healthy and has no problem in meeting its short term obligations.
BGS has a Current ratio of 3.30. This is amongst the best in the industry. BGS outperforms 85.39% of its industry peers.
A Quick Ratio of 1.14 indicates that BGS should not have too much problems paying its short term obligations.
Looking at the Quick ratio, with a value of 1.14, BGS is in the better half of the industry, outperforming 68.54% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 3.3
Quick Ratio 1.14
BGS Yearly Current Assets VS Current LiabilitesBGS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

3

3. Growth

3.1 Past

BGS shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -29.29%.
Measured over the past years, BGS shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -15.66% on average per year.
The Revenue has decreased by -6.29% in the past year.
Measured over the past years, BGS shows a small growth in Revenue. The Revenue has been growing by 3.08% on average per year.
EPS 1Y (TTM)-29.29%
EPS 3Y-27.93%
EPS 5Y-15.66%
EPS Q2Q%3.33%
Revenue 1Y (TTM)-6.29%
Revenue growth 3Y-2.05%
Revenue growth 5Y3.08%
Sales Q2Q%-4.59%

3.2 Future

Based on estimates for the next years, BGS will show a quite strong growth in Earnings Per Share. The EPS will grow by 11.47% on average per year.
The Revenue is expected to grow by 0.19% on average over the next years.
EPS Next Y-3.45%
EPS Next 2Y0.74%
EPS Next 3Y11.47%
EPS Next 5YN/A
Revenue Next Year-0.87%
Revenue Next 2Y-0.31%
Revenue Next 3Y0.19%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
BGS Yearly Revenue VS EstimatesBGS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 500M 1B 1.5B 2B
BGS Yearly EPS VS EstimatesBGS Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0.5 1 1.5 2

6

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 9.65, which indicates a very decent valuation of BGS.
BGS's Price/Earnings ratio is rather cheap when compared to the industry. BGS is cheaper than 85.39% of the companies in the same industry.
BGS is valuated cheaply when we compare the Price/Earnings ratio to 27.75, which is the current average of the S&P500 Index.
With a Price/Forward Earnings ratio of 9.99, the valuation of BGS can be described as very reasonable.
BGS's Price/Forward Earnings ratio is rather cheap when compared to the industry. BGS is cheaper than 92.13% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 20.49, BGS is valued rather cheaply.
Industry RankSector Rank
PE 9.65
Fwd PE 9.99
BGS Price Earnings VS Forward Price EarningsBGS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

BGS's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. BGS is cheaper than 73.03% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, BGS is valued cheaply inside the industry as 89.89% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 5.18
EV/EBITDA 8.33
BGS Per share dataBGS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 -10 20

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y0.74%
EPS Next 3Y11.47%

5

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 11.19%, BGS is a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 4.38, BGS pays a better dividend. On top of this BGS pays more dividend than 97.75% of the companies listed in the same industry.
BGS's Dividend Yield is rather good when compared to the S&P500 average which is at 2.44.
Industry RankSector Rank
Dividend Yield 11.19%

5.2 History

The dividend of BGS decreases each year by -16.37%.
BGS has been paying a dividend for at least 10 years, so it has a reliable track record.
BGS has decreased its dividend recently.
Dividend Growth(5Y)-16.37%
Div Incr Years0
Div Non Decr Years1
BGS Yearly Dividends per shareBGS Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1 2 3

5.3 Sustainability

BGS has negative earnings and hence a negative payout ratio. The dividend may be in danger.
DP-23.9%
EPS Next 2Y0.74%
EPS Next 3Y11.47%
BGS Yearly Income VS Free CF VS DividendBGS Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M -200M

B&G FOODS INC

NYSE:BGS (5/2/2025, 12:58:05 PM)

6.755

-0.05 (-0.81%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)02-25 2025-02-25/amc
Earnings (Next)05-07 2025-05-07/amc
Inst Owners69.72%
Inst Owner Change0.61%
Ins Owners3.08%
Ins Owner Change14.87%
Market Cap534.59M
Analysts48.57
Price Target7.43 (9.99%)
Short Float %18.42%
Short Ratio6.43
Dividend
Industry RankSector Rank
Dividend Yield 11.19%
Yearly Dividend0.76
Dividend Growth(5Y)-16.37%
DP-23.9%
Div Incr Years0
Div Non Decr Years1
Ex-Date03-31 2025-03-31 (0.19)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-17.06%
Min EPS beat(2)-35.09%
Max EPS beat(2)0.96%
EPS beat(4)1
Avg EPS beat(4)-16.92%
Min EPS beat(4)-35.09%
Max EPS beat(4)0.96%
EPS beat(8)5
Avg EPS beat(8)1.72%
EPS beat(12)6
Avg EPS beat(12)0.62%
EPS beat(16)6
Avg EPS beat(16)-1.6%
Revenue beat(2)0
Avg Revenue beat(2)-1.92%
Min Revenue beat(2)-3.51%
Max Revenue beat(2)-0.33%
Revenue beat(4)1
Avg Revenue beat(4)-1.25%
Min Revenue beat(4)-3.51%
Max Revenue beat(4)1%
Revenue beat(8)2
Avg Revenue beat(8)-1.3%
Revenue beat(12)4
Avg Revenue beat(12)-0.45%
Revenue beat(16)6
Avg Revenue beat(16)-0.45%
PT rev (1m)0%
PT rev (3m)-11.3%
EPS NQ rev (1m)-2.07%
EPS NQ rev (3m)-8.54%
EPS NY rev (1m)-0.47%
EPS NY rev (3m)1.93%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-1.61%
Revenue NY rev (1m)-0.16%
Revenue NY rev (3m)-0.62%
Valuation
Industry RankSector Rank
PE 9.65
Fwd PE 9.99
P/S 0.28
P/FCF 5.18
P/OCF 4.08
P/B 1.02
P/tB N/A
EV/EBITDA 8.33
EPS(TTM)0.7
EY10.36%
EPS(NY)0.68
Fwd EY10.01%
FCF(TTM)1.3
FCFY19.31%
OCF(TTM)1.65
OCFY24.49%
SpS24.42
BVpS6.63
TBVpS-16.55
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -8.39%
ROE -47.87%
ROCE 7.74%
ROIC 6.12%
ROICexc 6.23%
ROICexgc 19.33%
OM 11.04%
PM (TTM) N/A
GM 21.83%
FCFM 5.34%
ROA(3y)-3.53%
ROA(5y)-1.07%
ROE(3y)-19.04%
ROE(5y)-6.78%
ROIC(3y)5.46%
ROIC(5y)5.48%
ROICexc(3y)5.54%
ROICexc(5y)5.56%
ROICexgc(3y)18%
ROICexgc(5y)19.45%
ROCE(3y)6.91%
ROCE(5y)6.94%
ROICexcg growth 3Y2.98%
ROICexcg growth 5Y-1.12%
ROICexc growth 3Y8.5%
ROICexc growth 5Y3.01%
OM growth 3Y1.19%
OM growth 5Y-2.1%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.91%
GM growth 5Y-1.1%
F-Score4
Asset Turnover0.65
Health
Industry RankSector Rank
Debt/Equity 3.84
Debt/FCF 19.58
Debt/EBITDA 6.68
Cap/Depr 31.46%
Cap/Sales 1.43%
Interest Coverage 1.5
Cash Conversion 43.43%
Profit Quality N/A
Current Ratio 3.3
Quick Ratio 1.14
Altman-Z 1.48
F-Score4
WACC7.32%
ROIC/WACC0.84
Cap/Depr(3y)29.41%
Cap/Depr(5y)36.55%
Cap/Sales(3y)1.24%
Cap/Sales(5y)1.44%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-29.29%
EPS 3Y-27.93%
EPS 5Y-15.66%
EPS Q2Q%3.33%
EPS Next Y-3.45%
EPS Next 2Y0.74%
EPS Next 3Y11.47%
EPS Next 5YN/A
Revenue 1Y (TTM)-6.29%
Revenue growth 3Y-2.05%
Revenue growth 5Y3.08%
Sales Q2Q%-4.59%
Revenue Next Year-0.87%
Revenue Next 2Y-0.31%
Revenue Next 3Y0.19%
Revenue Next 5YN/A
EBIT growth 1Y-39.22%
EBIT growth 3Y-0.88%
EBIT growth 5Y0.92%
EBIT Next Year30.36%
EBIT Next 3Y12.24%
EBIT Next 5YN/A
FCF growth 1Y-53.52%
FCF growth 3Y27.08%
FCF growth 5Y90.64%
OCF growth 1Y-47.16%
OCF growth 3Y11.71%
OCF growth 5Y23%